All Columns articles – Page 8
- 
      
         Opinion OpinionKnocking down paywallsPresident Biden’s surprise announcement ending paywalls for federally-funded research by 2026 has left publishers scrambling to respond 
- 
      
          
- 
      
         Opinion OpinionWhy AlphaFold won’t revolutionise drug discoveryProtein structure prediction is a hard problem, but even harder ones remain 
- 
      
         Opinion OpinionReflections on rainwaterWater in the world’s pristine wildernesses is already unsafe to drink by new PFAS pollution standards 
- 
      
         Opinion OpinionMay cause side effectsThe dose makes the poison, but understanding unwanted drug interactions is complicated 
- 
      
         Opinion OpinionFarsighted scienceThe Webb telescope looks set to deliver on its promise to change the way we see the universe 
- 
      
         Opinion OpinionCan scientists communicate better with comedy?It’s no joke: scientists and comedians are collaborating to share research 
- 
      
          
- 
      
         Opinion OpinionAlzheimer’s, amyloid and abandoned antibodiesBiogen’s aducanumab is stumbling into obscurity. Where does that leave the amyloid hypothesis? 
- 
      
         Opinion OpinionEnergy is the Achilles’ heel of carbon capture technologiesEfforts to trap carbon dioxide could consume a huge amount of forecast renewable energy growth 
- 
      
         Opinion OpinionCatalogues of complexityThe tangled web of fine chemicals supply frequently throws up surprises 
- 
      
         Opinion OpinionReformed and refreshedChemistry comes out of the latest Research Excellence Framework exercise looking good 
- 
      
         Opinion OpinionExit strategyOvercoming a major setback showed Derek Lowe could make it through graduate school 
- 
      
         Opinion OpinionA spanner in the worksMost drugs work by breaking or stopping something, rather than by making something faster or better 
- 
      
          
- 
      
         Opinion OpinionDiversifying in two dimensionsArtisanal assemblies are opening up pathways to exciting and exotic phenomena 
- 
      
          
- 
      
         Opinion OpinionScents and sentimentalityDeprived of familiar lab odours, Derek Lowe indulges in some nasal nostalgia 
- 
      
         Opinion OpinionWhat next for the US’s China Initiative after the case against MIT’s Gang Chen falls apart?The US’s probe into researchers’ ties to China and potential theft of intellectual property stands on a knife edge 
- 
      
         Opinion OpinionThe law of conservation of dataAI and machine learning are useful and powerful, but they need high quality data inputs that aren’t available yet for drug discovery